Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Follow-up data

From: Therapeutic hypothermia in adult patients receiving extracorporeal life support: early results of a randomized controlled study

Variable All patients n = 21 (%) Hypothermia n = 9 (%) Normothermia n = 12 (%) P-value
Weaned from ECLS 12 (57.1) 4 (44.4) 8 (66.7) 0.309
Severe neurological dysfunction 13 (61.9) 6 (66.7) 7 (58.3) 0.697
Length of hospital stay (days) 7 (2, 22) 6 (2, 23) 7 (2, 22) 0.772
In-hospital death 15 (71.4) 6 (66.7) 9 (75.0) 0.676
Hospital discharge 5 (23.8) 3 (33.3) 2 (18.2) 0.436
Survival at 6 months 5 (23.8) 3 (33.3) 2 (18.2) 0.436
Survival (good neurological function) 3 (14.3) 2 (22.2) 1 (8.3) 0.368
  1. Values for non-parametric continuous variables are expressed as median followed by 25th and 75th percentiles. Values for categorical variables are expressed as numbers (%)
  2. ECLS extracorporeal life support